BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1846181)

  • 1. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
    Morrison HL; Dai HY; Pedersen FS; Lenz J
    J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element.
    Boral AL; Okenquist SA; Lenz J
    J Virol; 1989 Jan; 63(1):76-84. PubMed ID: 2535754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
    LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
    J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
    Nieves A; Levy LS; Lenz J
    J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
    Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
    J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus.
    Morrison HL; Soni B; Lenz J
    J Virol; 1995 Jan; 69(1):446-55. PubMed ID: 7983741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.
    Lenz J; Celander D; Crowther RL; Patarca R; Perkins DW; Haseltine WA
    Nature; 1984 Mar 29-Apr 4; 308(5958):467-70. PubMed ID: 6323995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
    Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
    J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
    Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS
    J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
    Pantginis J; Beaty RM; Levy LS; Lenz J
    J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.
    Hollon T; Yoshimura FK
    J Virol; 1989 Aug; 63(8):3353-61. PubMed ID: 2545910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression.
    Dai HY; Etzerodt M; Baekgaard AJ; Lovmand S; Jørgensen P; Kjeldgaard NO; Pedersen FS
    Virology; 1990 Apr; 175(2):581-5. PubMed ID: 2158188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
    Martiney MJ; Levy LS; Lenz J
    J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.
    Yoshimura FK; Tupper J; Diem K
    J Virol; 1989 Nov; 63(11):4945-8. PubMed ID: 2552174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL; Lenz J
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.
    Short MK; Okenquist SA; Lenz J
    J Virol; 1987 Apr; 61(4):1067-72. PubMed ID: 3029400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue specific sequence motifs in the enhancer of the leukaemogenic mouse retrovirus SL3-3.
    Hallberg B; Grundström T
    Nucleic Acids Res; 1988 Jul; 16(13):5927-44. PubMed ID: 2840634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY; Yang WK; Myer FE; Yang DM
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region.
    Celander D; Haseltine WA
    J Virol; 1987 Feb; 61(2):269-75. PubMed ID: 3027359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.